Asset Details
Do you wish to reserve the book?
Overcoming Resistance — Omission of Radiotherapy for Low-Risk Breast Cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Overcoming Resistance — Omission of Radiotherapy for Low-Risk Breast Cancer
Do you wish to request the book?
Overcoming Resistance — Omission of Radiotherapy for Low-Risk Breast Cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Overcoming Resistance — Omission of Radiotherapy for Low-Risk Breast Cancer
2023
Overview
In this issue of the
Journal
, Kunkler and colleagues
1
report the highly anticipated 10-year results of the PRIME II trial, which show that omission of radiotherapy did not affect survival after breast-conserving surgery in women 65 years of age or older with T1 or T2 (tumors ≤3 cm in the largest dimension), node-negative, estrogen receptor (ER)–positive breast cancer. These data offer a response to the long-standing problem of overtreatment in older women with low-risk breast cancer.
2
The ability to omit radiotherapy is one of many options in a lengthy list that also includes the use of abbreviated radiotherapy regimens and . . .
Publisher
Massachusetts Medical Society
Subject
